PRESS RELEASE
Lasart SRL, Turin, Italy -12 January 2026
Turin, Italy -Lasart SRL announces the launch of Lumicor, an innovative fluid cream designed for the safe and effective correction of hyperpigmentation. The product has been developed in full compliance with the latest European cosmetic safety regulations and is based on the most recent scientific evidence regarding the mechanisms of melanogenesis and skin inflammation.
Lumicor combines a clinically validated approach with next‑generation ingredients capable of delivering results comparable to hydroquinone, resorcinol, retinol and corticosteroids - without their side effects
Key strengths and innovations
Lumicor is the first product to integrate a clinically proven approach with modern, highly tolerable ingredients capable of acting on three levels:
- Inhibition of melanogenesis
- Highly purified curcumin - efficacy comparable to 4% hydroquinone, with a favorable safety profile.
- Niacinamide - blocks melanosome transfer and strengthens the skin barrier (+42% ceramide increase).
- Anti‑inflammatory action
- 5% tranexamic acid - reduces inflammatory mediators and erythema.
- Complex of 4 natural extracts - provides an effect similar to corticosteroids, but without steroid‑related risks.
- Cellular renewal
- Third‑generation retinoid - twice as effective as retinol and ten times less irritating than tretinoin; stimulates type I and III collagen.
Why it matters
According to the ALL Project study published in the Journal der Deutschen Dermatologischen Gesellschaft (September 2025), 2.4 million Italians suffer from various forms of hyperpigmentation.
Recent European restrictions on hydroquinone, resorcinol and retinoids have significantly reduced the availability of effective solutions. Lumicor addresses this need by offering a modern, safe product supported by solid scientific evidence.
Official statement
The new regulations governing cosmetic production shift the focus toward product safety and represent a challenge for formulators.
The elimination of hydroquinone, resorcinol and the restrictions on retinoids ensure greater consumer safety, but at the same time create a shortage of truly effective products. This limits the ability to address a widespread issue such as hyperpigmentation.
We have developed an innovative product that rigorously follows scientific principles and modern knowledge on hyperpigmentation. Advanced ingredients have allowed us to create this formula in full compliance with the new EU requirements for cosmetics
Information about Lumicor
- Skin type: all skin types
- Indications: hyperpigmentation, photoaging, PIH (post‑inflammatory hyperpigmentation)
- Manufactured in: Italy
- Format: 30 ml
- Texture: fluid and lightweight
- Comedogenicity: low, with reduced risk of imperfections
About Lasart
Lasart SRL (Turin, Italy) specializes in the development of skincare products, with a particular focus on skin regeneration after laser procedures and advanced dermatological treatments.
Epicalm™ and Melicor™ are registered trademarks of Lasart SRL.